Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome
Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2004-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2326 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839577136531243008 |
|---|---|
| author | S. S. Yakushin N. I. Ivankova N. S. Sazonova N. V. Vilesova G. O. Ivanova |
| author_facet | S. S. Yakushin N. I. Ivankova N. S. Sazonova N. V. Vilesova G. O. Ivanova |
| author_sort | S. S. Yakushin |
| collection | DOAJ |
| description | Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At baseline and 12 weeks later, blood pressure (BP) and heart rate (HR) dynamics was assessed by the data from 24-hour BP monitoring (BPM), echocardiography, and biochemical blood assay. Good clinical efficacy and tolerability of albarel was observed, without disturbances of lipid, carbohydrate, electrolyte, purin metabolism, functional status of liver and kidneys. Rilmenidine treatment was also associated with EchoCG parameters improvement. Rilmenidine was effective and safe in arterial hypertension treatment, demonstrating cardioprotective properties as well. |
| format | Article |
| id | doaj-art-58befe981e6e4afdadcb6b51a2dbe9d4 |
| institution | Matheson Library |
| issn | 1560-4071 2618-7620 |
| language | Russian |
| publishDate | 2004-12-01 |
| publisher | «FIRMA «SILICEA» LLC |
| record_format | Article |
| series | Российский кардиологический журнал |
| spelling | doaj-art-58befe981e6e4afdadcb6b51a2dbe9d42025-08-04T12:59:58Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202004-12-010657602072Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndromeS. S. Yakushin0N. I. Ivankova1N. S. Sazonova2N. V. Vilesova3G. O. Ivanova4Рязанский государственный медицинский университет им. акад. И.П.Павлова; Рязанский областной клинический кардиологический диспансерРязанский государственный медицинский университет им. акад. И.П.Павлова; Рязанский областной клинический кардиологический диспансерРязанский государственный медицинский университет им. акад. И.П.Павлова; Рязанский областной клинический кардиологический диспансерРязанский государственный медицинский университет им. акад. И.П.Павлова; Рязанский областной клинический кардиологический диспансерРязанский государственный медицинский университет им. акад. И.П.Павлова; Рязанский областной клинический кардиологический диспансерEfficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At baseline and 12 weeks later, blood pressure (BP) and heart rate (HR) dynamics was assessed by the data from 24-hour BP monitoring (BPM), echocardiography, and biochemical blood assay. Good clinical efficacy and tolerability of albarel was observed, without disturbances of lipid, carbohydrate, electrolyte, purin metabolism, functional status of liver and kidneys. Rilmenidine treatment was also associated with EchoCG parameters improvement. Rilmenidine was effective and safe in arterial hypertension treatment, demonstrating cardioprotective properties as well.https://russjcardiol.elpub.ru/jour/article/view/2326arterial hypertensionmetabolic syndromecardioprotective effectsrilmenidine |
| spellingShingle | S. S. Yakushin N. I. Ivankova N. S. Sazonova N. V. Vilesova G. O. Ivanova Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome Российский кардиологический журнал arterial hypertension metabolic syndrome cardioprotective effects rilmenidine |
| title | Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome |
| title_full | Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome |
| title_fullStr | Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome |
| title_full_unstemmed | Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome |
| title_short | Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome |
| title_sort | rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome |
| topic | arterial hypertension metabolic syndrome cardioprotective effects rilmenidine |
| url | https://russjcardiol.elpub.ru/jour/article/view/2326 |
| work_keys_str_mv | AT ssyakushin rilmenidinetreatmentinpatientswithmildtomoderatearterialhypertensionandmetabolicsyndrome AT niivankova rilmenidinetreatmentinpatientswithmildtomoderatearterialhypertensionandmetabolicsyndrome AT nssazonova rilmenidinetreatmentinpatientswithmildtomoderatearterialhypertensionandmetabolicsyndrome AT nvvilesova rilmenidinetreatmentinpatientswithmildtomoderatearterialhypertensionandmetabolicsyndrome AT goivanova rilmenidinetreatmentinpatientswithmildtomoderatearterialhypertensionandmetabolicsyndrome |